Abstract
Glutamic acid decarboxylase (GAD) is the enzyme responsible for the synthesis of gamma-aminobutyric acid (GABA). GAD has been identified as a 64-kDa antigen expressed in pancreatic beta-cells, to which autoantibodies are generated prior to the onset of type 1 (insulin-dependent) diabetes mellitus. GAD may therefore be an initiating factor in beta-cell destruction. We administered baclofen, a GABA-B receptor agonist, to non-obese diabetic (NOD) mice in an attempt to down-regulate GAD expression and thereby reduce the incidence of diabetes. Twenty-four female NOD mice were given baclofen in their drinking water at a final dose of 50 mg/kg body weight daily from weaning to 30 weeks of age. Twentyfour sex-and litter-matched mice were used as controls. At 30 weeks there was no difference in the incidence of diabetes in the treated group compared with the controls. However, there was a significant delay in the onset of diabetes in the treated group (P<0.001, parallelism test). The degree of insulitis and the GAD activity in the pancreas per mg of protein were unchanged by baclofen treatment with respect to controls. These results suggest that baclofen may be effective in delaying diabetes onset in NOD mice by stimulating GABA activity, as this neurotransmitter, localised in the islets, may modulate insulin secretion and the antigen expression associated with it.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkinson M, Maclaren NK, What causes diabetes? Sci Am 262:61–71, 1990
Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Bottazzo GF, Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147–149, 1990
Gianani R, Pugliese A, Bonner-Weir S, Schiffrin AJ, Soeldner JS, Erlich H, Awdeh Z Alper CA, Jackson RA, Eisenbarth GS, Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 41:347–353, 1992
Wilkin TJ, Autoantibodies as mechanisms, markers and mediators of B-cell disease. Diabetes Metab Rev 7:105–121, 1991
Baekkeskov S, Aanstot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P, Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156, 1990
Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ, 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335:1357–1360, 1990
Okada Y, Toniguchi H, Shimada C, High concentrations of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 194:620–622, 1976
Deaizpurua HJ, Harrison LC, Glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Diabetes Metab Rev. 8:133–147, 1992
Boitard C, Timsit J, Sempe P, Bach JF, Experimental immunoprevention of type diabetes mellitus. Diabetes Metab Rev 7:15–33, 1991
Atkinson MA, Maclaren NR, Lucchetta R, Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933–937, 1990
Gilon P, Tappas M, Remacle C, Localization of GAD-like immunoreactivity in the pancreas and stomach of the rat and mouse. Histochemistry 96:355–365, 1991
Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV, Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69–72, 1993
Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO, Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72–75, 1994
Pozzilli P, Signore A, Williams AJK, Beales PE, NOD mouse colonies around the world-recent facts and figures. Immunol Today 14:193–196, 1993
Signore A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL, The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32:282–289, 1989
Mansfield KJ, Beales PE, Williams AJK, Pozzilli P, The breeding, housing and life-maintenance of the non-obese diabetic mouse. Animal Technol 43:29–37, 1992
Principles of laboratory animal care. (NIH publication number 83-25, revised) 1985
Animals (Scientific Procedures) Act, 1986. Her Majesty's Stationery Office, London, 1986
Gianutsos G, Moore KE, Tolerance to the effects of baclofen and gamma-butyrolacetone on locomotor activity and dopaminergic neurons in the mouse. J Pharmacol Exp Ther 207:859–869, 1978
Rimvall K, Martin DL, Increased intracellular gamma-aminobutyric acid selectively lowers the level of the larger of two glutamate decarboxylase proteins in cultured GABAergic neurons from rat cerebral cortex. J Neurochem 58:158–166, 1992
Albers RW, Brady RO, The distribution of glutamic decarboxylase in the nervous system of the rhesus monkey. J Biol Chem 234:926–928, 1959
Christie MR, Brown TJ, Cassity D, Binding of antibodies in sera from type 1 (insulin dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35:380–384 1992
Pocock SJ, Analysis of survival data. In: Clinicial trials-a practical approach. Wiley, Chichester, pp 224–233, 1991
Cugini P, Leone G, Sepe M, De Palma L Parallelism test on microcomputers for statistically comparing regression lines of bivariate data sets. Comput Methods Prog Biomed 33:109–116, 1990
Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P, GABA and pancreatic β-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10:1275–1284, 1991
Zhang ZJ, Davidson I, Eisenbarth G, Weiner HL, Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci 88:10252–10256, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beales, P.E., Hawa, M., Williams, A.J.K. et al. Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse. Acta Diabetol 32, 53–56 (1995). https://doi.org/10.1007/BF00581047
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00581047